Volume 92, Issue 4 pp. 313-318
Full Access

DNA analysis as a tool to confirm the diagnosis of asymptomatic hereditary neuropathy with liability to pressure palsies (HNPP) with further evidence for the occurrence of de novo mutations

P. M. Gonnaud

Corresponding Author

P. M. Gonnaud

Service d'Explorations Fonctionnelles et Consultations Neurologiques, Centre Hospitalier Lyon-Sud

P.M. Gonnaud, SEFCN, Central Hospitalier Lyon-Sud, 69495 Pierre Benite Cédex, FranceSearch for more papers by this author
F. Sturtz

F. Sturtz

Progenitor Inc, Columbus, Ohio, USA

Search for more papers by this author
V. Fourbil

V. Fourbil

Laboratoire de Neurogénétique, Hôpital de l'Antiquaille, Lyon

Search for more papers by this author
C. Bonnebouche

C. Bonnebouche

Laboratoire de Neurogénétique, Hôpital de l'Antiquaille, Lyon

Search for more papers by this author
C. Tranchant

C. Tranchant

Service des Maladies du Système Nerveux et du Muscle, Hôpital Civil, Strasbourg

Search for more papers by this author
J. M. Warter

J. M. Warter

Service des Maladies du Système Nerveux et du Muscle, Hôpital Civil, Strasbourg

Search for more papers by this author
G. Chazot

G. Chazot

Service de Neurologie C Hôpital Neurologique, Lyon-Bron

Search for more papers by this author
B. Bady

B. Bady

Service de Neurologie, Centre Hospitalier de Chalon/Saône

Search for more papers by this author
C. Vial

C. Vial

Service d'Electromyographie. Hopital Neurologique. Lyon-Bron

Search for more papers by this author
A. S. Brechard

A. S. Brechard

Service de Neurologie, Centre Hospitalier de Chalon/Saône

Search for more papers by this author
A. Vandenberghe

A. Vandenberghe

Laboratoire de Neurogénétique, Hôpital de l'Antiquaille, Lyon

Faculté de Pharmacie, Université Claude Bernard Lyon, France

Search for more papers by this author
First published: October 1995
Citations: 9

Abstract

We performed DNA analysis in four families with hereditary neuropathy with liability to pressure palsy (HNPP). An interstitial deletion of the 17 p11.2 region was found in typically affected patients as well as in as yet asymptomatic patients. The opportunity for an individual genotyping permitted to ascertain a de novo deletion in one clinically affected case with no relevant familial history. DNA analysis thus becomes the most sensitive tool in diagnosing HNPP, since potentially affected patients may lack either informative familial history, or clinical symptoms or even suggestive EMG or histopathological data (tomaculas).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.